Crcm LP reported 10 positions worth $138.39M for the quarter ended Jun 30, 2026, down 1.1% on the prior quarter. It opened 5 new positions, added to 3, trimmed 2 and exited 2. Its largest holding is Ishares Gold Trust at 71.1% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| IBIT iShares Bitcoin Trust ETF | +303.6K | – | $10.11M | 7.3% |
| RNA Atrium Therapeutics, Inc. | +583.3K | – | $7.84M | 5.67% |
| BTGO Bitgo Holdings, Inc. | +1.31M | – | $6.80M | 4.91% |
| IAU Ishares Gold Trust | +52.5K | +4.2% | $3.96M | 71.06% |
| VZLA Vizsla Silver Corp. | +848.2K | – | $2.80M | 2.02% |
| TRAX First Tracks Biotherapeutics, Inc. | +35.3K | – | $711.04K | 0.514% |
| PCAP ProCap Acquisition Corp | +8,289 | +5.4% | $85.21K | 1.19% |
| AIFC AI Financial Corp | +90.0K | +0.7% | $52.66K | 5.37% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | IAU Ishares Gold Trust | Others | 1.30M | $98.34M | 71.06% | +52.5K | +4.2% | Added | 0.17% |
| 2 | IBIT iShares Bitcoin Trust ETF | Others | 303.6K | $10.11M | 7.3% | +303.6K | – | New | 0.02% |
| 3 | RNA Atrium Therapeutics, Inc. | Healthcare | 583.3K | $7.84M | 5.67% | +583.3K | – | New | 3.41% |
| 4 | AIFC AI Financial Corp | Technology | 12.70M | $7.43M | 5.37% | +90.0K | +0.7% | Added | 9.08% |
| 5 | BTGO Bitgo Holdings, Inc. | Technology | 1.31M | $6.80M | 4.91% | +1.31M | – | New | 1.12% |
| 6 | VZLA Vizsla Silver Corp. | Basic Materials | 848.2K | $2.80M | 2.02% | +848.2K | – | New | 0.24% |
| 7 | BNR Burning Rock Biotech Ltd | Healthcare | 212.0K | $1.77M | 1.28% | -70.1K | -24.8% | Reduced | 2.02% |
| 8 | PCAP ProCap Acquisition Corp | Financial Services | 160.7K | $1.65M | 1.19% | +8,289 | +5.4% | Added | 0.25% |
| 9 | PLBY Playboy, Inc. | Consumer Discretionary | 764.8K | $933.09K | 0.674% | -3.58M | -82.4% | Reduced | 0.65% |
| 10 | TRAX First Tracks Biotherapeutics, Inc. | Healthcare | 35.3K | $711.04K | 0.514% | +35.3K | – | New | 0.1% |
Tip. Select a row to see that position’s full history at Crcm.
As of its Q2 2026 13F filing, Crcm LP’s five largest positions were Ishares Gold Trust (IAU) at 71.1%, iShares Bitcoin Trust ETF (IBIT) at 7.3%, Atrium Therapeutics, Inc. (RNA) at 5.7%, AI Financial Corp (AIFC) at 5.4%, Bitgo Holdings, Inc. (BTGO) at 4.9% of the reported portfolio.
Crcm LP reported a 13F portfolio worth $138.39M across 10 positions for Q2 2026. That is down 1.1% from the previous quarter.
Its largest purchases by value were iShares Bitcoin Trust ETF ($10.11M), Atrium Therapeutics, Inc. ($7.84M), Bitgo Holdings, Inc. ($6.80M). It opened 5 new positions.
Its largest sales by value were Playboy, Inc. ($4.37M), Staar Surgical Co ($1.87M), Burning Rock Biotech Ltd ($586.74K). It exited 2 positions entirely.
From the Form 13F-HR reports Crcm LP files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.